Evidence map›Paper›PMID 33173647›Full record

ArticleCureus2020

Role of Montelukast as Monotherapy in Improving Quality of Life of an Asthmatic Patient in Pakistan.

Ankeeta Kumari, Mishal Ejaz, Khurram Anis, Sumeet Kumar, Besham Kumar, Sidra Memon

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Ankeeta KumariMedicine, Liaquat University of Medical and Health Sciences, Jamshoro, PAK.
Mishal EjazInternal Medicine, Ziauddin University, Karachi, PAK.
Khurram AnisGastroenterology/Hepatology, Pakistan Kidney and Liver Institute, Lahore, PAK.
Sumeet KumarInternal Medicine, Chandka Medical College Hospital, Larkana, PAK.
Besham KumarInternal Medicine, Jinnah Postgraduate Medical Centre, Karachi, PAK.
Sidra MemonInternal Medicine, Jinnah Sindh Medical University, Karachi, PAK.
Jinnah Postgraduate Medical Center · PKJinnah Sindh Medical University · PKLiaquat University of Medical & Health Sciences · PKZiauddin University · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionUncontrolled and inadequately managed asthma substantially reduces Quality of Life (QOL) and can lead to premature death. The aim of this study is to understand the role of montelukast in improving quality of life in asthmatic patients by comparing it with placebo.

methodsThis prospective, single-arm, interventional study was conducted from September 2019 to February 2020 in the pulmonology outpatient department of a tertiary care hospital in Pakistan. All patients were prescribed montelukast (10 mg once daily).

resultsAt day 28, participants had a higher score on the Asthma Quality of Life Questionnaire-Standard (AQLQ-S) overall and in all sub-domains compared to day 0. The improvement was significant overall and for the sub-domains of symptoms, activity limitations, and environmental stimuli.

conclusionMontelukast has an effective role in asthma control as well as in improving the quality of life in the Pakistani population.

Indexed as

montelukastpakistanquality of life

Identifiers

PMID33173647
PMCPMC7647844
OpenAlexW3091796680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.